{"text": "eisai completed the rolling bla submission for amyloid protofibril targeting antibody lecanemab biib"}
{"text": "esaly biib eisai wraps filing for biogen partnered aduhelm followup hoping to regain credibility and trust"}
{"text": "biib and eisai complete rolling submission of bla for lecanemab for early alzheimer s disease under the accelerated approval pathway esaly"}
{"text": "biib esaly eisai completes rolling submission to the u s fda for biologics license application of lecanemab for early alzheimer s disease under the accelerated approval pathway"}
{"text": "eisai completes rolling submission to the u s fda for biologics license application of lecanemab for early biib esaly tyo 4523"}
{"text": "biib eisai completes rolling submission to the u s fda for biologics license application of lecanemab for early alzheimer s disease under the accelerated approval pathway"}
